Angiotensin II Type 1 Receptor Antibody-Mediated Kidney Rejection Unresponsive to Treatment.

apheresis therapy at1r antibody kidney allograft non-hla antibody renal transplant rejection therapeutic plasma exchange (tpe)

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2023
Historique:
accepted: 25 06 2023
medline: 31 7 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

Allograft rejection is a significant cause of renal transplant failure which needs prompt diagnosis and treatment for graft salvage. Angiotensin II type 1 receptor antibody-mediated rejection (AT1R-AMR) is increasingly being identified as the etiology of antibody-mediated rejection in kidney transplant recipients with allograft rejection but without detectable human leukocyte antigen (HLA) antibodies. While some reports have suggested that AT1R-AMR may be refractory to standard therapy, others have reported improvement or stabilization of graft function. We present two patients in which anti-rejection therapy including therapeutic plasma exchange was unable to salvage the allograft.

Identifiants

pubmed: 37519536
doi: 10.7759/cureus.41007
pmc: PMC10371875
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e41007

Informations de copyright

Copyright © 2023, Allison et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Transplant Rev (Orlando). 2020 Oct;34(4):100573
pubmed: 33002671
Transplant Proc. 2021 Jun;53(5):1501-1508
pubmed: 33573814
Nephrology (Carlton). 2015 Mar;20 Suppl 1:10-2
pubmed: 25807851
Nephrol Dial Transplant. 2010 Jun;25(6):1998-2004
pubmed: 20100733
Cleve Clin J Med. 2018 Feb;85(2):138-144
pubmed: 29425089
Am J Transplant. 2023 Feb;23(2 Suppl 1):S21-S120
pubmed: 37132350
Transpl Int. 2014 Oct;27(10):1029-38
pubmed: 24909812
Transplant Proc. 2018 Apr;50(3):877-880
pubmed: 29331505
J Clin Apher. 2018 Dec;33(6):673-677
pubmed: 30321467
N Engl J Med. 2005 Feb 10;352(6):558-69
pubmed: 15703421
Nephrology (Carlton). 2015 Jul;20(7):467-73
pubmed: 25726938
Transplant Proc. 2015 Apr;47(3):649-52
pubmed: 25891704
Transplantation. 2018 Nov;102(11):1795-1814
pubmed: 30028786

Auteurs

David Allison (D)

Pathology, University of Illinois at Chicago, Chicago, USA.

Zahraa Hajjiri (Z)

Transplant Nephrology, University of Illinois at Chicago, Chicago, USA.

Luis Manon (L)

Pathology, University of Illinois at Chicago, Chicago, USA.

Sally Campbell-Lee (S)

Pathology, University of Illinois at Chicago, Chicago, USA.

Suhalika Sahni (S)

Pathology, University of Illinois at Chicago, Chicago, USA.

Suman Setty (S)

Pathology, University of Illinois at Chicago, Chicago, USA.

Classifications MeSH